Yaz Lawsuit Funding
The oral contraceptives Yaz and Yasmin are the source of growing litigation, as thousands of women allege that Bayer Pharmaceuticals – manufacturers of the drugs – failed to warn consumers of the possible risks associated with fourth-generation pills. Formulated with drospirenone, Yaz, Yasmin, and Ocella (the generic version of the pills) have been linked to a range of serious complications and fatal heart conditions. Multiple studies have shown that drospirenone may increase the risk of blood clot formation and related injuries, and since their approval in 2001 and 2006, the Food and Drug Administration (FDA) has received hundreds of reports involving injuries and sudden deaths among women who took pills made with drospirenone. Individuals who have already taken legal action against Bayer and are awaiting their settlements may be eligible for Yasmin & Yaz lawsuit funding – a risk-free cash advance against your pending case.
Who can file Yaz lawsuits?
Women who have experienced debilitating side effects as a result of taking Yaz or Yasmin birth control pills may be eligible to file a lawsuit to request compensation for their injuries. Plaintiffs who have already filed lawsuits cite Bayer’s deceptive advertising practices and failure to warn of potentially dangerous side effects and risks associated with Yaz, Yasmin, and Ocella. These plaintiffs may now be eligible to receive Yaz lawsuit funding as they await resolution to their cases.
Yaz side effects reported among women
Thousands of women who took Yaz, Yasmin, or Ocella have reported severe and sometimes life-threatening injuries from the birth control pills. Among the most common side effects and complications alleged by Yaz users and their loved ones are:
- Blood clot formation
- Deep vein thrombosis (DVT)
- Stroke
- Heart arrhythmia
- Hyperkalemia
- Cerebral hemorrhage
- High blood pressure
- Liver cancer or tumor formation
- Heart attack
- Pulmonary embolism
- Gallbladder disease
- Sudden death
FDA warns of potential Yaz risks
Fourth generation oral contraceptives containing drospirenone such as Yaz, Yasmin, and Ocella have been linked to serious health risks, which have been backed up by medical studies. A 2009 report in the British Medical Journal found that women who took Yaz or Yasmin had twice the risk of injury due to blood clots than those who took older birth control pills.
In 2011, the Food and Drug Administration (FDA) issued a drug safety communication concerning Yaz-related side effects, particularly blood clots, stating that they were investigating the safety of drospirenone. That same year, the FDA announced their review of two clinical studies where women who ingested drospirenone-containing pills proved to be up to three times more likely to develop blood clots compared to those using older oral contraceptives.
Current status of Yaz litigation
In response to the thousands of women who filed Yaz/Yasmin lawsuits against Bayer, federal cases were centralized for multidistrict litigation (MDL No. 2100) proceedings in the Southern District of Illinois. Presided over by Judge David R. Herndon, the Yaz MDL has more than 14,000 cases, making it the largest multidistrict litigation in the United States at this time. Other claims have been coordinated for mass litigation in Philadelphia, Los Angeles and New Jersey. While Bayer is currently negotiating settlements with plaintiffs who suffered deep vein thrombosis (DVT) or pulmonary embolism linked to Yaz, it may be many months before funds are dispersed. The pharmaceutical company has already reached agreements in some 3,500 cases, and is expected to pay out around $750 million in damages. But the question is – when will this happen? It could easily be twelve months or longer before Yaz plaintiffs could see a dime of their settlement funds.
How does Yaz lawsuit funding work?
If you are interested in dangerous drug lawsuit funding for a potential or current case against Bayer, LawStreet Capital can help. We provide non-recourse loans against Yaz and Yasmin lawsuits. While it may be labeled a “loan,” Yaz & Yasmin litigation funding is actually a cash advance based on the predicted outcome of your case. This type of legal funding poses no risk to you, the borrower, since you’ll only be asked to repay the funds if you win or successfully settle your Yaz claim. If an attorney is currently handling your case on a contingency fee basis, you may be eligible for a cash advance to fund your Yaz lawsuit or simply cover daily living expenses while you await your Yaz settlement.
Benefits of pre settlement loans
While Yaz litigation carries on in both state and federal courts, many claimants face a growing pile of medical bills associated with their injuries, and some may be unable to work. Rather than take an early settlement or be forced into bankruptcy, an increasing number of plaintiffs are considering Yaz lawsuit funding to help them make ends meet. With pre settlement lawsuit funding, you can ensure your case is litigated to the fullest extent, helping you recover maximum compensation for your needless suffering.
Why choose LawStreet Capital?
The market is flooded with myriad legal funding companies offering cash advances to fund Yaz side effects lawsuits, but LawStreet Capital is the nation’s most trusted provider. Since we’re a direct lender, there is no middle man involved, which equals the industry’s most competitive interest rates and the best service for our customers. If you’re under financial strain and could use a quick influx of cash to help pursue a fair Yaz settlement or jury award, please consider pre settlement loans with us. Unlike a traditional bank loan, there’s no employment verification, credit checks or monthly payments required, and our application is free. Once approved, your funds will be wired or sent via overnight mail in just 24 hours. It’s just that simple! To learn more about your future with Yaz lawsuit funding, please call our professional customer representatives at LawStreet Capital today at 1-800-345-8500.
